FDA Inspection 864562 — Anna Lowczak
The FDA completed an inspection of Anna Lowczak on January 30, 2014 in Prabuty. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 30, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Prabuty (Poland)
Additional Details
Sponsor, Contract Research Organization